128 related articles for article (PubMed ID: 9607431)
1. Use of pamidronate in the management of acute cancer-related hypercalcemia in children.
Kutluk T; Akyüz C; Yalçin B; Varan A; Büyükpamuküçu M
Med Pediatr Oncol; 1998 Jul; 31(1):39. PubMed ID: 9607431
[No Abstract] [Full Text] [Related]
2. Metabolic disturbances after a single dose of 30 mg pamidronate for leukaemia-associated hypercalcaemia in a 11-year-old boy.
De Schepper J; de Pont S; Smitz J; De Coster D; Schots R; Otten J
Eur J Pediatr; 1999 Sep; 158(9):765-6. PubMed ID: 10485313
[No Abstract] [Full Text] [Related]
3. Electrolyte abnormalities with zoledronic acid therapy.
Sorscher SM
Cancer J; 2002; 8(4):348; author reply 348-9. PubMed ID: 12184414
[No Abstract] [Full Text] [Related]
4. Childhood cancer and hypercalcemia: report of a case treated with pamidronate.
Kutluk MT; Hazar V; Akyüz C; Varan A; Büyükpamukçu M
J Pediatr; 1997 May; 130(5):828-31. PubMed ID: 9152297
[TBL] [Abstract][Full Text] [Related]
5. Multiple electrolyte abnormalities after pamidronate administration.
Elisaf M; Kalaitzidis R; Siamopoulos KC
Nephron; 1998; 79(3):337-9. PubMed ID: 9678436
[TBL] [Abstract][Full Text] [Related]
6. Severe prolonged hypocalcaemia following pamidronate for malignant hypercalcaemia.
Sims EC; Rogers PB; Besser GM; Plowman PN
Clin Oncol (R Coll Radiol); 1998; 10(6):407-9. PubMed ID: 9890546
[TBL] [Abstract][Full Text] [Related]
7. Symptomatic hypocalcemia in a patient with latent hypoparathyroidism and breast carcinoma with bone metastasis following administration of pamidronate.
Cömlekçi A; Biberoglu S; Hekimsoy Z; Okan I; Pişkin O; Sekeroglu B; Alakavuklar M
Intern Med; 1998 Apr; 37(4):396-7. PubMed ID: 9630201
[TBL] [Abstract][Full Text] [Related]
8. Pamidronate and calcitonin as therapy of acute cancer-related hypercalcemia in children.
Schmid I; Stachel D; Schön C; Bauer M; Haas RJ
Klin Padiatr; 2001; 213(1):30-4. PubMed ID: 11225473
[TBL] [Abstract][Full Text] [Related]
9. Hypercalcemia and childhood cancer: a 7-year experience.
Kerdudo C; Aerts I; Fattet S; Chevret L; Pacquement H; Doz F; Michon J; Garabedian M; Orbach D
J Pediatr Hematol Oncol; 2005 Jan; 27(1):23-7. PubMed ID: 15654274
[TBL] [Abstract][Full Text] [Related]
10. Use of pamidronate in the management of acute cancer-related hypercalcemia in children.
Young G; Shende A
Med Pediatr Oncol; 1998 Feb; 30(2):117-21. PubMed ID: 9403021
[TBL] [Abstract][Full Text] [Related]
11. Update on the medical treatment of hypercalcemia of malignancy.
Hall TG; Schaiff RA
Clin Pharm; 1993 Feb; 12(2):117-25. PubMed ID: 8453860
[TBL] [Abstract][Full Text] [Related]
12. Treatment of acute lymphoblastic leukemia-induced extreme hypercalcemia with pamidronate and calcitonin.
Mathur M; Sykes JA; Saxena VR; Rao SP; Goldman GM
Pediatr Crit Care Med; 2003 Apr; 4(2):252-5. PubMed ID: 12749663
[TBL] [Abstract][Full Text] [Related]
13. Hypocalcemia following pamidronate administration for bone metastases of solid tumor: three clinical case reports.
Champallou C; Basuyau JP; Veyret C; Chinet P; Debled M; Chevrier A; Grongnet MH; Brunelle P
J Pain Symptom Manage; 2003 Feb; 25(2):185-90. PubMed ID: 12590034
[TBL] [Abstract][Full Text] [Related]
14. Symptomatic hypocalcemia after intravenous pamidronate.
McIntyre E; Bruera E
J Palliat Care; 1996; 12(1):46-7. PubMed ID: 8857248
[TBL] [Abstract][Full Text] [Related]
15. Use of bisphosphonates for resistant hypercalcemia in children with acute lymphoblastic leukemia: report of two cases and review of the literature.
Andiran N; Alikaşifoğlu A; Küpeli S; Yetgin S
Turk J Pediatr; 2006; 48(3):248-52. PubMed ID: 17172070
[TBL] [Abstract][Full Text] [Related]
16. [Pamidronate in the treatment of tumor-associated hypercalcemia].
Pecherstorfer M; Janisch S; Marosi C; Wogritsch C; Bosse C; Schratzberger W; Gerber E; Fortelny A; Lenzhofer R; Rainer H
Klin Wochenschr; 1991 Oct; 69(15):690-5. PubMed ID: 1795492
[TBL] [Abstract][Full Text] [Related]
17. Pamidronate-induced irreversible symptomatic hypocalcemia in a dog with hypercalcemia after glucocorticoid withdrawal: a case report.
Oh YI; An JH; Lim GH; Park SM; Kim TH; Seo KW; Youn HY
BMC Vet Res; 2024 May; 20(1):227. PubMed ID: 38790012
[TBL] [Abstract][Full Text] [Related]
18. Symptomatic hypocalcaemia following intravenous pamidronate in cancer patients.
Chong G; Hoang T; Davis ID
Aust N Z J Med; 1999 Feb; 29(1):96-7. PubMed ID: 10200826
[No Abstract] [Full Text] [Related]
19. Intravenous pamidronate for hypercalcemia of primary hyperparathyroidism.
Tal A; Graves L
South Med J; 1996 Jun; 89(6):637-40. PubMed ID: 8638211
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of hypercalcemia of malignancy with pamidronate in a patient with advanced recurrent oral cancer].
Nishimura N; Matsushita Y; Takaoka K; Hashitani S; Noguchi K; Urade M
Gan To Kagaku Ryoho; 2002 Dec; 29(13):2537-9. PubMed ID: 12506478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
